Mutual Of America Capital Management LLC Vaxcyte, Inc. Transaction History
Mutual Of America Capital Management LLC
- $9.12 Billion
- Q4 2024
A detailed history of Mutual Of America Capital Management LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 25,270 shares of PCVX stock, worth $954,195. This represents 0.02% of its overall portfolio holdings.
Number of Shares
25,270
Previous 50,341
49.8%
Holding current value
$954,195
Previous $5.75 Million
64.02%
% of portfolio
0.02%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding PCVX
# of Institutions
349Shares Held
126MCall Options Held
539KPut Options Held
253K-
Vanguard Group Inc Valley Forge, PA12MShares$452 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$399 Million0.46% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$375 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$328 Million11.52% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.21MShares$235 Million0.11% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.24B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...